Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323984 · ClinicalTrials.gov registry record
Postoperative Delirium in Hip Arthroplasty Patients
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 49
- Enrollment target
NCT02323984: Completed study, sponsored by Ohio State University.
NCT02323984 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323984 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Identification of specific circulating microRNAs and microemboli formation (diagnosed by TC Doppler) in both delirious groups and nondelirious group will be our primary target. Delirium assessment through standardized questionnaires will be done at baseline (day of the surgery - pre operatory), immediately after surgery (in post anesthesia care unit) and then every 12 hours in Day 1 and Day2 after surgery. The investigators will use linear mixed models to describe the change patterns overtime, and compare differences at each time point. Inflammatory biomarkers will be explored overtime as well. The investigators will also explore age effect on cognitive function - cognitive reserve - based on the score of the cognitive test administered at baseline.
Primary Outcome
Identification of specific circulating microRNAs and microemboli formation (diagnosed by TC Doppler) in both delirious groups and nondelirious group will be our primary target. Our overarching goal is to identify novel early clinical indicators of cognitive dysfunction (e.g. Delirium and POCD)
Interventions
- OTHER miRNA Testing, Microemboli Monitoring, Delirium Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-03 |
What the finished NCT02323984 record still lists
NCT02323984 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which miRNA Testing, Microemboli Monitoring, Delirium Assessment is the first listed.
NCT02323984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02323984 about?
NCT02323984 is a clinical study titled "Postoperative Delirium in Hip Arthroplasty Patients". Identification of specific circulating microRNAs and microemboli formation (diagnosed by TC Doppler) in both delirious groups and nondelirious group will be our primary target. Delirium assessment through standardized questionnaires will be done at baseline (day of the surgery - pre operatory), imme...
What is the current status of trial NCT02323984?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2014-01. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02323984?
The interventions under investigation include: miRNA Testing, Microemboli Monitoring, Delirium Assessment (OTHER).
Who is sponsoring clinical trial NCT02323984?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia